Implications of eGFR Dip Following SGLT2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Implications of Estimated Glomerular Filtration Rate Dip Following Sodium-Glucose Cotransporter-2 Inhibitor Initiation on Cardiovascular and Kidney Outcomes
J Am Heart Assoc 2021 Jun 01;10(11)e020237, Y Xie, B Bowe, AK Gibson, JB McGill, G Maddukuri, Z Al-AlyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.